SlideShare a Scribd company logo
1 of 2
Download to read offline
VARIANT SPECIFIC ANNOTATIONS
AN ANNOTATIONS in GeneTalk is a user-generated content that is specific to a genomic position. It can contain
information about a genetic disorder or a link to a scientific article. Users can rate annotations in the category MEDICAL RELEVANCE and SCIENTIFIC EVIDENCE. Additionally users can provide comments to provide information or start
a discussion.

1.
2.
3.

Genomic position of the first nucleotide affected
Genotype or allele
Gene name and Entrez ID

4.

HGVS codes for DNA and protein level

5.
6.
7.
8.
9.

Author of annotation
Visibility to GeneTalk community
Annotation Text
Your rating for medical relevance and scientific evidence
User who provided a comment

Opens a new window at http://omim.org/

13. Link to publication in Pubmed

Opens the gene info viewer
Referring to the first affected letter in cDNA or protein

Contact user directly by clicking the mail button

10. Add your comment

11. Link to external source or website
12. OMIM-ID

Opens a new window at www.ncbi.nlm.nih.gov/pubmed/

14. Link to MutationTaster
Opens a new window at http://www.mutationtaster.org/ to
evaluates disease-causing potential of sequence alterations

15.
16.
17.
18.
19.

www.gene-talk.de

Star rating for medical relevance
Star rating for scientific evidence
Votes of all users
Click the VOTE button to apply your rating
Comment of a user
ANNOTATION RATING AND FILTERING
RATING OF ANNOTATIONS: The ratings in the category MEDICAL RELEVANCE range from one star (irrelevant or artifact) to five stars (disease
causing) and in the category SCIENTIFIC EVIDENCE from one star (very
low (e.g. incidental finding)) to five stars (very high (e.g. therapy studies)). Newly created annotations have to be rated by the user for medical relevance and scientific evidence. The initial rating of user counts as
three votes and every further rating as one.

Irrelevant or artifact
Suspicious
Disease associated
Disease modifying
Disease causing
Very low (e.g. incidental finding)

THE STAR RATING OF THE CATEGORIES medical relevance and scientific
evidence is based on the majority vote of the user community. Users
can adjust their rating at any time. The rating of the category changes as
soon as a new majority of users is found. The displayed star rating of an
annotation represents the majority of votes. All ratings are anonymous
but a vote counter shows the distribution of all ratings of the users.
GENETALK’S KOWLEDGEBASE: GeneTalk combined existing annotations from publicly available databases such as
HGMD, dbSNP and the 1000 genomes project
(1kGP). All annotations from the dbSNP that are flagged
as clinically precious and HGMD annotations that are
termed disease causing are initially rated with five stars
for medical relevance and scientific evidence. Technical
sequencing artifacts from the 1kGP blacklist were initially
rated with one star for medical relevance and five stars
for scientific evidence.
FILTER

VARIANTS BY MEDICAL RELEVANCE AND SCI-

ENTIFIC EVIDENCE:

You can set the annotation filter
to any level of medical relevance and scientific evidence. If the filter is set to two stars in medical
relevance for example all sequencing artifacts and
irrelevant variants will be removed. As a first approach in a diagnostic filtering procedure it might
be reasonable to start with a five star rating for
medical relevance and at least a two star rating for
scientific evidence. The total number of variants is
most effectively reduced when only variants with
annotations are kept. This setting can be used to
check whether there are variants in a data set
with already annotated mutation. If a patient cannot be diagnosed with this setting it is a more
complicated research question and other filtering
parameters have to be carefully chosen.

www.gene-talk.de

Low (e.g. multiple cases)
Medium (e.g. functional assays)
High (e.g. animal models)
Very high (e.g. therapy studies)

More Related Content

What's hot

BioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryBioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryJosef Scheiber
 
Embase indexing (webinar 28 oct)
Embase indexing (webinar 28 oct)Embase indexing (webinar 28 oct)
Embase indexing (webinar 28 oct)Ann-Marie Roche
 
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...David Peyruc
 
Scientists Develop Polygenic Test for Coronary Artery Disease Risk
Scientists Develop Polygenic Test for Coronary Artery Disease RiskScientists Develop Polygenic Test for Coronary Artery Disease Risk
Scientists Develop Polygenic Test for Coronary Artery Disease RiskRajan Bhatt
 
Aries systems eemug 2021 manuscript eval services panel sci score v2_edits
Aries systems eemug 2021 manuscript eval services panel sci score v2_editsAries systems eemug 2021 manuscript eval services panel sci score v2_edits
Aries systems eemug 2021 manuscript eval services panel sci score v2_editsAnita Bandrowski
 
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review?
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review? Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review?
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review? Ivan Oransky
 
Linked data-and-sp ls-fda-spl-jamboree-092014
Linked data-and-sp ls-fda-spl-jamboree-092014Linked data-and-sp ls-fda-spl-jamboree-092014
Linked data-and-sp ls-fda-spl-jamboree-092014Richard Boyce, PhD
 
Covering Medical Studies: How Not to Get It Wrong
Covering Medical Studies: How Not to Get It WrongCovering Medical Studies: How Not to Get It Wrong
Covering Medical Studies: How Not to Get It WrongIvan Oransky
 
Drug Pioneer Research - Drug information sources
Drug Pioneer Research - Drug information sourcesDrug Pioneer Research - Drug information sources
Drug Pioneer Research - Drug information sourcesLucia Ravi
 
Pharmacogenomics annotation in drug structured product labeling for clinical ...
Pharmacogenomics annotation in drug structured product labeling for clinical ...Pharmacogenomics annotation in drug structured product labeling for clinical ...
Pharmacogenomics annotation in drug structured product labeling for clinical ...Richard Boyce, PhD
 
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...Wimmics seminar--drug interaction knowledge base, micropublication, open anno...
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...jodischneider
 
What Is Peer Review?
What Is Peer Review?What Is Peer Review?
What Is Peer Review?Jerry Stovall
 
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...jodischneider
 
Linking assertions to evidence with the MicroPublications ontology WG evidenc...
Linking assertions to evidence with the MicroPublications ontology WG evidenc...Linking assertions to evidence with the MicroPublications ontology WG evidenc...
Linking assertions to evidence with the MicroPublications ontology WG evidenc...jodischneider
 
Overcoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative diseaseOvercoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative diseaseLona Vincent
 
The Retraction Watch Database
The Retraction Watch DatabaseThe Retraction Watch Database
The Retraction Watch DatabaseIvan Oransky
 
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014Richard Boyce, PhD
 
Regulatory Medical Writing: The Challenges of Writing Patient Narratives
Regulatory Medical Writing: The Challenges of Writing Patient Narratives Regulatory Medical Writing: The Challenges of Writing Patient Narratives
Regulatory Medical Writing: The Challenges of Writing Patient Narratives Cognibrain Healthcare
 

What's hot (20)

BioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryBioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug Discovery
 
Embase indexing (webinar 28 oct)
Embase indexing (webinar 28 oct)Embase indexing (webinar 28 oct)
Embase indexing (webinar 28 oct)
 
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Advancing tranSMART Analy...
 
Scientists Develop Polygenic Test for Coronary Artery Disease Risk
Scientists Develop Polygenic Test for Coronary Artery Disease RiskScientists Develop Polygenic Test for Coronary Artery Disease Risk
Scientists Develop Polygenic Test for Coronary Artery Disease Risk
 
Aries systems eemug 2021 manuscript eval services panel sci score v2_edits
Aries systems eemug 2021 manuscript eval services panel sci score v2_editsAries systems eemug 2021 manuscript eval services panel sci score v2_edits
Aries systems eemug 2021 manuscript eval services panel sci score v2_edits
 
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review?
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review? Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review?
Fraud and Why Studies are Flawed: Should Journalists Trust Peer Review?
 
Linked data-and-sp ls-fda-spl-jamboree-092014
Linked data-and-sp ls-fda-spl-jamboree-092014Linked data-and-sp ls-fda-spl-jamboree-092014
Linked data-and-sp ls-fda-spl-jamboree-092014
 
Covering Medical Studies: How Not to Get It Wrong
Covering Medical Studies: How Not to Get It WrongCovering Medical Studies: How Not to Get It Wrong
Covering Medical Studies: How Not to Get It Wrong
 
FDA Issues Guidance For IRBs Feb 2010
FDA Issues Guidance For IRBs  Feb 2010FDA Issues Guidance For IRBs  Feb 2010
FDA Issues Guidance For IRBs Feb 2010
 
Drug Pioneer Research - Drug information sources
Drug Pioneer Research - Drug information sourcesDrug Pioneer Research - Drug information sources
Drug Pioneer Research - Drug information sources
 
Pharmacogenomics annotation in drug structured product labeling for clinical ...
Pharmacogenomics annotation in drug structured product labeling for clinical ...Pharmacogenomics annotation in drug structured product labeling for clinical ...
Pharmacogenomics annotation in drug structured product labeling for clinical ...
 
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...Wimmics seminar--drug interaction knowledge base, micropublication, open anno...
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...
 
What Is Peer Review?
What Is Peer Review?What Is Peer Review?
What Is Peer Review?
 
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
 
Linking assertions to evidence with the MicroPublications ontology WG evidenc...
Linking assertions to evidence with the MicroPublications ontology WG evidenc...Linking assertions to evidence with the MicroPublications ontology WG evidenc...
Linking assertions to evidence with the MicroPublications ontology WG evidenc...
 
Overcoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative diseaseOvercoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative disease
 
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
 
The Retraction Watch Database
The Retraction Watch DatabaseThe Retraction Watch Database
The Retraction Watch Database
 
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014
Addressing gaps-in-clinically-useful-evidence-on-dd is-nlm-training-2014
 
Regulatory Medical Writing: The Challenges of Writing Patient Narratives
Regulatory Medical Writing: The Challenges of Writing Patient Narratives Regulatory Medical Writing: The Challenges of Writing Patient Narratives
Regulatory Medical Writing: The Challenges of Writing Patient Narratives
 

Viewers also liked

Diagnóstico y manejo de las cefaleas secundarias
Diagnóstico y manejo de las cefaleas secundariasDiagnóstico y manejo de las cefaleas secundarias
Diagnóstico y manejo de las cefaleas secundariasGuillermo Enriquez
 
Cefalea 22 def
Cefalea 22 defCefalea 22 def
Cefalea 22 defkurtvi
 
Cefaleas guía de actuación en atención primaria
Cefaleas guía de actuación en atención primariaCefaleas guía de actuación en atención primaria
Cefaleas guía de actuación en atención primariaeparacuellos
 
Lóbulos Cerebrales: La corteza cerebral
Lóbulos Cerebrales: La corteza cerebralLóbulos Cerebrales: La corteza cerebral
Lóbulos Cerebrales: La corteza cerebralJoel Ricci-López
 
ExploracióN Neurológica 08
ExploracióN Neurológica 08ExploracióN Neurológica 08
ExploracióN Neurológica 08Rafael Bárcena
 
Mecanismos fisiopatologicos de la cefalea
Mecanismos fisiopatologicos de la cefaleaMecanismos fisiopatologicos de la cefalea
Mecanismos fisiopatologicos de la cefaleaVOTATE
 
(2012-09-20)Cefalea diagnostíco y tratamiento.ppt
(2012-09-20)Cefalea diagnostíco y tratamiento.ppt(2012-09-20)Cefalea diagnostíco y tratamiento.ppt
(2012-09-20)Cefalea diagnostíco y tratamiento.pptUDMAFyC SECTOR ZARAGOZA II
 
hemisferios y lobulos cerebrales
hemisferios y lobulos cerebraleshemisferios y lobulos cerebrales
hemisferios y lobulos cerebralesLeonardo Hernandez
 

Viewers also liked (20)

Clinica cefalea no migranosa
Clinica cefalea no migranosaClinica cefalea no migranosa
Clinica cefalea no migranosa
 
Enfermedad Vascular Cerebral
Enfermedad Vascular CerebralEnfermedad Vascular Cerebral
Enfermedad Vascular Cerebral
 
Migraña
MigrañaMigraña
Migraña
 
Epilepsia Y Sus Definicones
Epilepsia Y Sus DefiniconesEpilepsia Y Sus Definicones
Epilepsia Y Sus Definicones
 
Diagnóstico y manejo de las cefaleas secundarias
Diagnóstico y manejo de las cefaleas secundariasDiagnóstico y manejo de las cefaleas secundarias
Diagnóstico y manejo de las cefaleas secundarias
 
Ascitis y encefalopatia
Ascitis y encefalopatiaAscitis y encefalopatia
Ascitis y encefalopatia
 
Cefaleas y patologia vascular cerebral.
Cefaleas y patologia vascular cerebral.Cefaleas y patologia vascular cerebral.
Cefaleas y patologia vascular cerebral.
 
Manejo de las cefaleas en atencion primaria
Manejo de las cefaleas en atencion primaria Manejo de las cefaleas en atencion primaria
Manejo de las cefaleas en atencion primaria
 
Cefalea 22 def
Cefalea 22 defCefalea 22 def
Cefalea 22 def
 
Migraña
MigrañaMigraña
Migraña
 
Cefaleas guía de actuación en atención primaria
Cefaleas guía de actuación en atención primariaCefaleas guía de actuación en atención primaria
Cefaleas guía de actuación en atención primaria
 
Migraña 3
Migraña 3Migraña 3
Migraña 3
 
Lóbulos Cerebrales: La corteza cerebral
Lóbulos Cerebrales: La corteza cerebralLóbulos Cerebrales: La corteza cerebral
Lóbulos Cerebrales: La corteza cerebral
 
Lobulos cerebrales
Lobulos cerebralesLobulos cerebrales
Lobulos cerebrales
 
ExploracióN Neurológica 08
ExploracióN Neurológica 08ExploracióN Neurológica 08
ExploracióN Neurológica 08
 
Sindromes Neurologicos
Sindromes NeurologicosSindromes Neurologicos
Sindromes Neurologicos
 
Mecanismos fisiopatologicos de la cefalea
Mecanismos fisiopatologicos de la cefaleaMecanismos fisiopatologicos de la cefalea
Mecanismos fisiopatologicos de la cefalea
 
(2012-09-20)Cefalea diagnostíco y tratamiento.ppt
(2012-09-20)Cefalea diagnostíco y tratamiento.ppt(2012-09-20)Cefalea diagnostíco y tratamiento.ppt
(2012-09-20)Cefalea diagnostíco y tratamiento.ppt
 
Cefalea
CefaleaCefalea
Cefalea
 
hemisferios y lobulos cerebrales
hemisferios y lobulos cerebraleshemisferios y lobulos cerebrales
hemisferios y lobulos cerebrales
 

Similar to GeneTalk Annotation Whitepaper

Comparing research designs fw 2013 handout version
Comparing research designs fw 2013 handout versionComparing research designs fw 2013 handout version
Comparing research designs fw 2013 handout versionPat Barlow
 
Current BioData\'s new databases for the Business Of Biology
Current BioData\'s new databases for the Business Of BiologyCurrent BioData\'s new databases for the Business Of Biology
Current BioData\'s new databases for the Business Of Biologyjjacketti
 
Trial Types_PIIS0092867420302099.pdf
Trial Types_PIIS0092867420302099.pdfTrial Types_PIIS0092867420302099.pdf
Trial Types_PIIS0092867420302099.pdfDr Ashraful Islam
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres finalprasath172
 
What is research and.docx
What is research and.docxWhat is research and.docx
What is research and.docxwrite22
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 projectmdragoescu
 
medical-test-reviews-genetic.ppt
medical-test-reviews-genetic.pptmedical-test-reviews-genetic.ppt
medical-test-reviews-genetic.pptssuser2cad2a
 
Pharmaceutical Predictivity May 2010
Pharmaceutical Predictivity May 2010Pharmaceutical Predictivity May 2010
Pharmaceutical Predictivity May 2010Thorir Bjornsson
 
Strategies For Answering Clinical Queries
Strategies For Answering Clinical QueriesStrategies For Answering Clinical Queries
Strategies For Answering Clinical QueriesRobin Featherstone
 
The Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision MedicineThe Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision Medicinemhaendel
 
MedicalResearch.com: Medical Research Interviews
MedicalResearch.com:  Medical Research InterviewsMedicalResearch.com:  Medical Research Interviews
MedicalResearch.com: Medical Research InterviewsMarie Benz MD FAAD
 
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... 	 Personalized ...Personalized Medicine: Balancing the Promise and Peril of ... 	 Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...MedicineAndHealth
 
study design of clinical research
study design of clinical researchstudy design of clinical research
study design of clinical researchMD Jahidul Islam
 
K7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfK7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfJeslynTengkawan1
 
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...DNA Compass
 

Similar to GeneTalk Annotation Whitepaper (20)

Comparing research designs fw 2013 handout version
Comparing research designs fw 2013 handout versionComparing research designs fw 2013 handout version
Comparing research designs fw 2013 handout version
 
OBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptxOBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptx
 
Current BioData\'s new databases for the Business Of Biology
Current BioData\'s new databases for the Business Of BiologyCurrent BioData\'s new databases for the Business Of Biology
Current BioData\'s new databases for the Business Of Biology
 
Duzkale_2013_Variant Interpretation_
Duzkale_2013_Variant Interpretation_Duzkale_2013_Variant Interpretation_
Duzkale_2013_Variant Interpretation_
 
NEUROCYSTICERCOSIS
NEUROCYSTICERCOSISNEUROCYSTICERCOSIS
NEUROCYSTICERCOSIS
 
Trial Types_PIIS0092867420302099.pdf
Trial Types_PIIS0092867420302099.pdfTrial Types_PIIS0092867420302099.pdf
Trial Types_PIIS0092867420302099.pdf
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres final
 
Cohort study
Cohort studyCohort study
Cohort study
 
What is research and.docx
What is research and.docxWhat is research and.docx
What is research and.docx
 
2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project2010StanfordE25 Michele dragoescu e25 project
2010StanfordE25 Michele dragoescu e25 project
 
medical-test-reviews-genetic.ppt
medical-test-reviews-genetic.pptmedical-test-reviews-genetic.ppt
medical-test-reviews-genetic.ppt
 
Pharmaceutical Predictivity May 2010
Pharmaceutical Predictivity May 2010Pharmaceutical Predictivity May 2010
Pharmaceutical Predictivity May 2010
 
Strategies For Answering Clinical Queries
Strategies For Answering Clinical QueriesStrategies For Answering Clinical Queries
Strategies For Answering Clinical Queries
 
The Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision MedicineThe Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision Medicine
 
NGS-report-amir.pdf
NGS-report-amir.pdfNGS-report-amir.pdf
NGS-report-amir.pdf
 
MedicalResearch.com: Medical Research Interviews
MedicalResearch.com:  Medical Research InterviewsMedicalResearch.com:  Medical Research Interviews
MedicalResearch.com: Medical Research Interviews
 
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... 	 Personalized ...Personalized Medicine: Balancing the Promise and Peril of ... 	 Personalized ...
Personalized Medicine: Balancing the Promise and Peril of ... Personalized ...
 
study design of clinical research
study design of clinical researchstudy design of clinical research
study design of clinical research
 
K7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfK7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdf
 
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...
Possible Solution for Managing the Worlds Personal Genetic Data - DNA Guide, ...
 

Recently uploaded

Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of PlayPooky Knightsmith
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxakanksha16arora
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...Nguyen Thanh Tu Collection
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17Celine George
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningMarc Dusseiller Dusjagr
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111GangaMaiya1
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfNirmal Dwivedi
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfPondicherry University
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17Celine George
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....Ritu480198
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSAnaAcapella
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use CasesTechSoup
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 

Recently uploaded (20)

Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 

GeneTalk Annotation Whitepaper

  • 1. VARIANT SPECIFIC ANNOTATIONS AN ANNOTATIONS in GeneTalk is a user-generated content that is specific to a genomic position. It can contain information about a genetic disorder or a link to a scientific article. Users can rate annotations in the category MEDICAL RELEVANCE and SCIENTIFIC EVIDENCE. Additionally users can provide comments to provide information or start a discussion. 1. 2. 3. Genomic position of the first nucleotide affected Genotype or allele Gene name and Entrez ID 4. HGVS codes for DNA and protein level 5. 6. 7. 8. 9. Author of annotation Visibility to GeneTalk community Annotation Text Your rating for medical relevance and scientific evidence User who provided a comment Opens a new window at http://omim.org/ 13. Link to publication in Pubmed Opens the gene info viewer Referring to the first affected letter in cDNA or protein Contact user directly by clicking the mail button 10. Add your comment 11. Link to external source or website 12. OMIM-ID Opens a new window at www.ncbi.nlm.nih.gov/pubmed/ 14. Link to MutationTaster Opens a new window at http://www.mutationtaster.org/ to evaluates disease-causing potential of sequence alterations 15. 16. 17. 18. 19. www.gene-talk.de Star rating for medical relevance Star rating for scientific evidence Votes of all users Click the VOTE button to apply your rating Comment of a user
  • 2. ANNOTATION RATING AND FILTERING RATING OF ANNOTATIONS: The ratings in the category MEDICAL RELEVANCE range from one star (irrelevant or artifact) to five stars (disease causing) and in the category SCIENTIFIC EVIDENCE from one star (very low (e.g. incidental finding)) to five stars (very high (e.g. therapy studies)). Newly created annotations have to be rated by the user for medical relevance and scientific evidence. The initial rating of user counts as three votes and every further rating as one. Irrelevant or artifact Suspicious Disease associated Disease modifying Disease causing Very low (e.g. incidental finding) THE STAR RATING OF THE CATEGORIES medical relevance and scientific evidence is based on the majority vote of the user community. Users can adjust their rating at any time. The rating of the category changes as soon as a new majority of users is found. The displayed star rating of an annotation represents the majority of votes. All ratings are anonymous but a vote counter shows the distribution of all ratings of the users. GENETALK’S KOWLEDGEBASE: GeneTalk combined existing annotations from publicly available databases such as HGMD, dbSNP and the 1000 genomes project (1kGP). All annotations from the dbSNP that are flagged as clinically precious and HGMD annotations that are termed disease causing are initially rated with five stars for medical relevance and scientific evidence. Technical sequencing artifacts from the 1kGP blacklist were initially rated with one star for medical relevance and five stars for scientific evidence. FILTER VARIANTS BY MEDICAL RELEVANCE AND SCI- ENTIFIC EVIDENCE: You can set the annotation filter to any level of medical relevance and scientific evidence. If the filter is set to two stars in medical relevance for example all sequencing artifacts and irrelevant variants will be removed. As a first approach in a diagnostic filtering procedure it might be reasonable to start with a five star rating for medical relevance and at least a two star rating for scientific evidence. The total number of variants is most effectively reduced when only variants with annotations are kept. This setting can be used to check whether there are variants in a data set with already annotated mutation. If a patient cannot be diagnosed with this setting it is a more complicated research question and other filtering parameters have to be carefully chosen. www.gene-talk.de Low (e.g. multiple cases) Medium (e.g. functional assays) High (e.g. animal models) Very high (e.g. therapy studies)